# Autologous Fecal Microbiota Transplantation for Anal Function Recovery After Ileostomy Reversal in Rectal Cancer

> **NCT07711509** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 35 (actual)

## Conditions studied

- Rectal Cancer
- Low Anterior Resection Syndrome
- Fecal Incontinence
- Diversion Colitis
- Ileostomy
- Gut Microbiota Dysbiosis

## Interventions

- **BIOLOGICAL:** Autologous Fecal Microbiota Transplantation

## Key facts

- **NCT ID:** NCT07711509
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-03-25
- **Primary completion:** 2026-05-20
- **Final completion:** 2026-09-01
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2026-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07711509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07711509, "Autologous Fecal Microbiota Transplantation for Anal Function Recovery After Ileostomy Reversal in Rectal Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07711509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*